Slavkovský Rastislav Ph.D.
Journals
IDH1/2 Mutations in Patients With Diffuse Gliomas.
Applied Immunohistochemistry and Molecular Morphology.
2021,
30(3),
178-183,
ISSN: 1541-2016,
PMID: 35262523,
Development and extensive analytical validation of deep amplicon sequencing for detecting KRAS and NRAS mutations in metastatic colorectal cancer samples.
Neoplasma.
2021,
69(1),
203-2015,
ISSN: 0028-2685,
PMID: 34881628,
Master mentorship
Csergeova Lucia
Genotyping of tumor somatic biomarkers using multi-parallel sequencing technologies with molecular barcodes features
Status:
Graduated from 2019 to 2021.
Vysloužilová Lenka
Significance assessment of gene variants identified by next-generation sequencing associated with inherited cardiomyopathies
Status:
Graduated from 2017 to 2019.
Bachelor mentorship
Csergeova Lucia
Genotyping of tumor biomarkers using novel multi-parallel sequencing technologies with an emphasis on ultra sesnsitive typing of circulating tumor DNA
Status:
Graduated from 2017 to 2019.
Blaťák Ondřej
Novel approaches for diagnostics of mutations of genes involved in age-related clonal haematopoiesis
Status:
Ongoing from 2023.
Open positions
Project: | Genetic and epigenetic biomarkers of cancer diseases |
---|---|
Supervisors: | Slavkovský Rastislav Ph.D., Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D. |
Available: | 3 |
Intended for: | Doctoral training |
Summary: | 3 places in full-time study |
Project: | Genetic and epigenetic biomarkers in cancer |
---|---|
Supervisors: | Drábek Jiří Ph.D., Slavkovský Rastislav Ph.D., Hajdúch Marián M.D., Ph.D. |
Available: | 3 |
Intended for: | Doctoral training |
Summary: | Clonal hematopoiesis of indeterminate potential (CHIP) has recently been described as a common phenomenon associated with aging. It is characterized by the accumulation of somatic mutations in cells of the hematopoietic system. Although CHIP is manifested by the expansion of certain cell clones, this condition is not accompanied by any morphological features of hematological neoplasia. However, it has been shown that the incidence of clonal hematopoiesis correlates with increased overall mortality and the risk of developing malignant transformation of hematopoietic cells as well as cardiovascular disease, such as ischemic stroke. To what extent and by what mechanisms clonal hematopoiesis contributes to disease development remains a question of current research. The main aim of the project will be to pinpoint the principal cells carrying CHIP somatic mutations, and to study their role in development and maintenance of atherosclerotic plaques, especially of those involved in development of stroke. The comparison of the phenotype of CHIP positive and negative cells will be of special interest. The use of cellular models not only include different types of leucocytes but circulatory progenitor endothelial cells as well. The study will involve elderly subjects with the positive presence of CHIP (>65 years). Subject will be characterized based on the presence or absence of ischemic stroke and the presence or absence of carotid stenosis by our clinical collaborators. The presence of somatic variants in 38 selected genes associated with CHIP will be tested in subjects of interest within our research group. The project will use various techiques including FACS, MACS, cell cultures, DNA isolation from small amount of cells, a highly sensitive sequencing method for DNA genotyping allowing detection of variant with less than 1% allelic frequency, DNA/RNA sequencing library preparation, deep massively parallel sequencing of panel of genes using unique molecular barcodes/indices, RNAseq, bioinformatics and data analysis with possibilities of calculations using high performance computing cluster, data management and statistical evaluation. |
Project: | Genetic and epigenetic biomarkers in health and disease |
---|---|
Supervisors: | Slavkovský Rastislav Ph.D., Džubák Petr M.D., Ph.D., Hajdúch Marián M.D., Ph.D., Drábek Jiří Ph.D., Koudeláková Vladimíra Ph.D. |
Available: | 5 |
Intended for: | Doctoral training |